Charles River Laboratories International, Inc. (NYSE:CRL) will look for acquisitions. James C. Foster, Chairman, Chief Executive Officer & President said “we will continue to, for sure, to do more M&A to build out that portfolio, both width and depth and invest aggressively in them. Acquisition pipeline is -- we're quite active right now, there's a lot out there. Most of it's private-equity owned or privately owned, and we don't have a lot of strategic competition for a lot of deals. I will be not necessarily disappointed but surprised if we don't do some M&A in fiscal 2019.”